Uniqure NV Form 4 insider transactions

Director David D. Meek acquired shares and options in uniQure N.V. on June 19, 2024, according to a Form 4 filing.

Director Madhavan Balachandran reports acquisition of restricted share units and stock options, along with disposal of ordinary shares.

Director Kaye Jack reports acquisition of restricted share units and stock options in uniQure N.V.

Director Leonard Post acquired 8,080 ordinary shares and 15,840 stock options in uniQure N.V. on June 19, 2024.

Director Jacques Rachelle Suzanne reports acquisition of restricted share units and stock options, along with disposal of shares, in uniQure N.V.

Chief Operating Officer Pierre Caloz sold 2,936 ordinary shares of uniQure N.V. to cover withholding taxes upon the vesting of restricted share units.

Christian Klemt, CFO of uniQure N.V., sold 1,611 ordinary shares to cover withholding taxes upon the vesting of restricted share units.

Director Leonard E. Post sold 2,222 ordinary shares of uniQure N.V. on June 13, 2024, to cover estimated withholding taxes upon vesting of restricted share units.

Jeannette Potts, Chief Legal Officer of uniQure N.V., sold shares to cover tax obligations arising from the vesting of restricted share units.

Director Jeremy P. Springhorn sold 2,231 ordinary shares of uniQure N.V. to cover tax obligations arising from the vesting of restricted share units.

Director David D. Meek sold 2,229 ordinary shares of uniQure N.V. on June 13, 2024, to cover withholding taxes upon vesting of restricted share units.

Director Madhavan Balachandran sold 2,231 ordinary shares of uniQure N.V. to cover estimated withholding taxes upon vesting of restricted share units.

Director Paula Soteropoulos sold 2,220 ordinary shares of uniQure N.V. to cover estimated withholding taxes upon vesting of restricted share units.

Director Robert Gut sold 3,504 ordinary shares of uniQure N.V. to cover withholding taxes upon vesting of restricted share units.

Director Jack Kaye sold 2,218 ordinary shares of uniQure N.V. on June 13, 2024, to cover estimated withholding taxes upon vesting of restricted share units.

Director Rachelle Suzanne Jacques sold 2,221 ordinary shares of uniQure N.V. to cover withholding taxes upon vesting of restricted share units.

CEO Matthew Kapusta of uniQure N.V. was granted stock options and restricted share units, increasing his beneficial ownership in the company.

Christian Klemt, Chief Financial Officer of uniQure N.V., reports the acquisition of restricted share units and a stock option grant.

Chief Medical Officer of uniQure, Walid Abi-Saab, reports acquisition of restricted share units and stock options, as well as disposal of shares.

Chief Operating Officer Pierre Caloz of uniQure N.V. reports acquisition of restricted share units and stock options.

Jeannette Potts, Chief Legal Officer of uniQure N.V., reports the acquisition of restricted share units and stock options, as well as the disposal of ordinary shares.

Pierre Caloz, Chief Operating Officer of uniQure N.V., sold shares to cover tax obligations arising from the vesting of restricted share units.

Christian Klemt, CFO of uniQure N.V., sold 15,906 ordinary shares to cover tax obligations arising from the vesting of restricted share units.

uniQure's CEO, Matthew Kapusta, sold 27,904 ordinary shares to cover tax obligations arising from the vesting of restricted share units.